{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:53:38Z","timestamp":1764831218402,"version":"3.46.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.7759\/cureus.98415","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:58:37Z","timestamp":1764824317000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Hiba","family":"Al Azeez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mena","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.10.005","article-title":"Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause","volume":"254","author":"Lobo RA","year":"2016","unstructured":"Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis. 2016, 254:282-90. 10.1016\/j.atherosclerosis.2016.10.005","journal-title":"Atherosclerosis"},{"key":"ref2","article-title":"Estrogen-progestin menopausal hormone therapy","volume":"4","author":"Kaunitz AM","year":"2022","unstructured":"Kaunitz AM. Estrogen-progestin menopausal hormone therapy. UpToDate. 2022, 4:16-8.","journal-title":"UpToDate"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","author":"The NAMS 2022 Hormone Therapy Position Statement Editorial Panel","year":"2022","unstructured":"The NAMS 2022 Hormone Therapy Position Statement Editorial Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022, 29:767-94. 10.1097\/GME.0000000000002028","journal-title":"Menopause"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-025-08161-w","article-title":"Endometrial thickness and pathology in postmenopausal women with bleeding on transdermal 17\u03b2-estradiol plus body-identical progesterone","volume":"312","author":"Glynne S","year":"2025","unstructured":"Glynne S, Kamal A, Neville A, McColl L, Naji O, Newson L, Reisel D. Endometrial thickness and pathology in postmenopausal women with bleeding on transdermal 17\u03b2-estradiol plus body-identical progesterone. Arch Gynecol Obstet. 2025, 312:1705-17. 10.1007\/s00404-025-08161-w","journal-title":"Arch Gynecol Obstet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5746","article-title":"Diagnosis and management of menopause: summary of NICE guidance","volume":"351","author":"Sarri G","year":"2015","unstructured":"Sarri G, Davies M, Lumsden MA. Diagnosis and management of menopause: summary of NICE guidance. BMJ. 2015, 351:h5746. 10.1136\/bmj.h5746","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1343298","article-title":"Safety and benefit considerations for menopausal hormone therapy","volume":"16","author":"Pickar JH","year":"2017","unstructured":"Pickar JH, Archer DF, Kagan R, Pinkerton JV, Taylor HS. Safety and benefit considerations for menopausal hormone therapy. Expert Opin Drug Saf. 2017, 16:941-54. 10.1080\/14740338.2017.1343298","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.13.1610","article-title":"Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review","volume":"288","author":"Clark TJ","year":"2002","unstructured":"Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002, 288:1610-21. 10.1001\/jama.288.13.1610","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2024.11.008","article-title":"Re-evaluating endometrial thickness in symptomatic postmenopausal patients for excluding cancer: systematic review and meta-analysis","volume":"22","author":"Chee RK","year":"2025","unstructured":"Chee RK, Koshy RM, Haidey J, Murad MH, Low G, Wilson MP. Re-evaluating endometrial thickness in symptomatic postmenopausal patients for excluding cancer: systematic review and meta-analysis. J Am Coll Radiol. 2025, 22:425-35. 10.1016\/j.jacr.2024.11.008","journal-title":"J Am Coll Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2025.04.007","article-title":"Molecular subtyping and the 2023 FIGO staging in endometrial cancer: redefining adjuvant therapy","volume":"64","author":"Lin H","year":"2025","unstructured":"Lin H, Ou YC, Fu HC, Huang SW, Wu CH, Changchien CC. Molecular subtyping and the 2023 FIGO staging in endometrial cancer: redefining adjuvant therapy. Taiwan J Obstet Gynecol. 2025, 64:616-24. 10.1016\/j.tjog.2025.04.007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082749","article-title":"Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trial","volume":"14","author":"Lundell C","year":"2024","unstructured":"Lundell C, Stergiopoulos N, Blomberg L, et al.. Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trial. BMJ Open. 2024, 14:e082749. 10.1136\/bmjopen-2023-082749","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.05.013","article-title":"Hormone replacement therapy and the risk of endometrial cancer: a systematic review","volume":"91","author":"Sj\u00f6gren LL","year":"2016","unstructured":"Sj\u00f6gren LL, M\u00f8rch LS, L\u00f8kkegaard E. Hormone replacement therapy and the risk of endometrial cancer: a systematic review. Maturitas. 2016, 91:25-35. 10.1016\/j.maturitas.2016.05.013","journal-title":"Maturitas"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.802959","article-title":"Association between hormone replacement therapy and development of endometrial cancer: results from a prospective US cohort study","volume":"8","author":"Liang Y","year":"2021","unstructured":"Liang Y, Jiao H, Qu L, Liu H. Association between hormone replacement therapy and development of endometrial cancer: results from a prospective US cohort study. Front Med (Lausanne). 2021, 8:802959. 10.3389\/fmed.2021.802959","journal-title":"Front Med (Lausanne)"},{"key":"ref13","unstructured":"National Cancer Institute. Endometrial Cancer Prevention (PDQ\u00ae)-Health Professional Version. (2025). Accessed: December 3, 2025: https:\/\/www.cancer.gov\/types\/uterine\/hp\/endometrial-prevention-pdq."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003712","article-title":"The use of hysteroscopy for the diagnosis and treatment of intrauterine pathology: ACOG Committee Opinion, Number 800","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","unstructured":"American College of Obstetricians and Gynecologists. The use of hysteroscopy for the diagnosis and treatment of intrauterine pathology: ACOG Committee Opinion, Number 800. Obstet Gynecol. 2020, 135:e138-48. 10.1097\/AOG.0000000000003712","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrras.2025.101509","article-title":"Endometrial thickness and its diagnostic utility in postmenopausal women: A retrospective analysis of ultrasound and histopathological findings","volume":"18","author":"Qiu S","year":"2025","unstructured":"Qiu S, Wu S, Song Y, Wang B, Dong XY. Endometrial thickness and its diagnostic utility in postmenopausal women: A retrospective analysis of ultrasound and histopathological findings. J Radiat Res Appl Sci. 2025, 18:101509-1687. 10.1016\/j.jrras.2025.101509","journal-title":"J Radiat Res Appl Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422503-the-impact-of-hormone-replacement-therapy-on-endometrial-pathology-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T04:58:38Z","timestamp":1764824318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422503-the-impact-of-hormone-replacement-therapy-on-endometrial-pathology-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.98415","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}